Cambridge Nutritional Science

CNSL · AIM · Health Care · mcap £3.6m · 1.5p

Beta Briefing, track record and bull & bear case are not ready for Cambridge Nutritional Science yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 38 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Mar 26

Source: results 08 Sep 26 ↗

Revenue: £7.0m
Operating profit: −£4.5m
Net income: −£5.8m
Free cash flow: −£2.1m
Net cash: £2.6m
Market cap: £3.7m
EV / EBIT: –
FCF yield: −57.5%
Price / book: 0.6×

Latest half-year · H1 Sep 25 vs H1 Sep 24 results 10 Nov 25 ↗

Revenue: £3.9m
Operating profit: −£435k
Net income: −£397k
Cash from operations: −£776k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: FY Mar 26 (twelve months to 31 Mar 26), published 08 Sep 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	FY Mar 26	FY Mar 25
Revenue	7.0	8.3
Gross profit	4.3	5.4
Adjusted operating profit	(1.2)	(0.4)
Exceptional / adjusting items	(3.3)	1.8
Operating profit	(4.5)	1.4
Amortisation	0.5	0.4
Share-based payments	0.2	0.2
Profit before tax	(4.4)	1.6
Net income (owners)	(5.8)	1.6
EPS basic	(2.4p)	0.7p
EPS diluted	(2.4p)	0.7p

	H2 Mar 26	H1 Sep 25	H2 Mar 25	H1 Sep 24
Revenue	3.1	3.9	4.2	4.1
Gross profit	1.7	2.6	2.7	2.7
Adjusted EBITDA	–	0.1	–	–
EBITDA	–	(0.1)	–	–
Exceptional / adjusting items	(3.1)	(0.1)	1.9	(0.1)
Operating profit	(4.0)	(0.4)	1.7	(0.3)
Amortisation	0.2	0.2	0.2	0.2
Share-based payments	0.1	0.1	0.1	0.1
Profit before tax	(4.0)	(0.4)	1.8	(0.2)
Net income (owners)	(5.4)	(0.4)	1.8	(0.2)
EPS basic	(2.2p)	(0.2p)	0.8p	(0.1p)

	FY Mar 26	FY Mar 25
Cash from operations	(1.2)	(0.1)
Capex (PP&E)	(0.3)	(0.2)
Capex (intangibles)	(0.6)	(0.2)
Lease principal paid	(0.1)	(0.1)
Lease interest paid	(0.0)	(0.0)

	H2 Mar 26	H1 Sep 25	H2 Mar 25	H1 Sep 24
Cash from operations	(0.4)	(0.8)	0.5	(0.6)
Capex (PP&E)	(0.1)	(0.2)	(0.1)	(0.1)
Capex (intangibles)	(0.3)	(0.2)	0.0	(0.2)
Lease principal paid	(0.1)	(0.1)	(0.1)	(0.1)
Lease interest paid	(0.0)	(0.0)	(0.0)	(0.0)

	FY Mar 26	FY Mar 25
Other intangibles	0.9	3.8
Property, plant & equipment	0.7	0.5
Inventories	0.7	0.8
Trade receivables	2.4	2.0
Cash	2.6	4.9
Current assets	5.6	7.7
Total assets	7.4	13.7
Trade payables	1.6	1.9
Borrowings, current	0.0	0.1
Lease liabilities, current	0.1	0.1
Current liabilities	1.7	2.1
Lease liabilities, non-current	0.0	0.1
Total liabilities	1.7	2.2
Total equity	5.7	11.4

	H2 Mar 26	H1 Sep 25	H2 Mar 25	H1 Sep 24
Goodwill	–	3.0	–	–
Other intangibles	0.9	–	3.8	–
Property, plant & equipment	0.7	0.7	0.5	0.5
Inventories	0.7	0.7	0.8	0.8
Trade receivables	2.4	2.3	2.0	2.2
Cash	2.6	3.6	4.9	4.5
Current assets	5.6	6.6	7.7	7.5
Total assets	7.4	12.7	13.7	13.5
Trade payables	1.6	1.4	1.9	1.2
Borrowings, current	0.0	0.1	0.1	0.0
Lease liabilities, current	0.1	0.1	0.1	0.1
Current liabilities	1.7	1.6	2.1	1.3
Lease liabilities, non-current	0.0	0.1	0.1	0.0
Total liabilities	1.7	1.6	2.2	4.0
Total equity	5.7	11.1	11.4	9.5
Shares in issue	–	238.0m	–	–

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.